180 related articles for article (PubMed ID: 17392286)
1. Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells.
Jin W; Reiley WR; Lee AJ; Wright A; Wu X; Zhang M; Sun SC
J Biol Chem; 2007 May; 282(21):15884-93. PubMed ID: 17392286
[TBL] [Abstract][Full Text] [Related]
2. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
3. A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.
Liu S; Lv J; Han L; Ichikawa T; Wang W; Li S; Wang XL; Tang D; Cui T
Biochem Biophys Res Commun; 2012 Mar; 420(1):78-83. PubMed ID: 22406061
[TBL] [Abstract][Full Text] [Related]
4. CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling.
Lee AJ; Wu X; Cheng H; Zhou X; Cheng X; Sun SC
J Biol Chem; 2010 May; 285(21):15696-703. PubMed ID: 20233721
[TBL] [Abstract][Full Text] [Related]
5. Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD.
Wright A; Reiley WW; Chang M; Jin W; Lee AJ; Zhang M; Sun SC
Dev Cell; 2007 Nov; 13(5):705-716. PubMed ID: 17981138
[TBL] [Abstract][Full Text] [Related]
6. Differential requirement of IKK2 for CYLD-dependent representation of thymic and peripheral T-cell populations.
Tsagaratou A; Grammenoudi S; Mosialos G
Eur J Immunol; 2011 Oct; 41(10):3054-62. PubMed ID: 21728169
[TBL] [Abstract][Full Text] [Related]
7. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
[TBL] [Abstract][Full Text] [Related]
8. CYLD is a crucial negative regulator of innate immune response in Escherichia coli pneumonia.
Lim JH; Ha UH; Woo CH; Xu H; Li JD
Cell Microbiol; 2008 Nov; 10(11):2247-56. PubMed ID: 18643924
[TBL] [Abstract][Full Text] [Related]
9. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
Sun SC
Cell Death Differ; 2010 Jan; 17(1):25-34. PubMed ID: 19373246
[TBL] [Abstract][Full Text] [Related]
10. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses.
Reiley WW; Jin W; Lee AJ; Wright A; Wu X; Tewalt EF; Leonard TO; Norbury CC; Fitzpatrick L; Zhang M; Sun SC
J Exp Med; 2007 Jun; 204(6):1475-85. PubMed ID: 17548520
[TBL] [Abstract][Full Text] [Related]
11. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner.
Tsagaratou A; Trompouki E; Grammenoudi S; Kontoyiannis DL; Mosialos G
J Immunol; 2010 Aug; 185(4):2032-43. PubMed ID: 20644164
[TBL] [Abstract][Full Text] [Related]
12. Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice.
Zhang J; Stirling B; Temmerman ST; Ma CA; Fuss IJ; Derry JM; Jain A
J Clin Invest; 2006 Nov; 116(11):3042-9. PubMed ID: 17053834
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7.
Yoshida H; Jono H; Kai H; Li JD
J Biol Chem; 2005 Dec; 280(49):41111-21. PubMed ID: 16230348
[TBL] [Abstract][Full Text] [Related]
14. Naturally occurring short splice variant of CYLD positively regulates dendritic cell function.
Srokowski CC; Masri J; Hövelmeyer N; Krembel AK; Tertilt C; Strand D; Mahnke K; Massoumi R; Waisman A; Schild H
Blood; 2009 Jun; 113(23):5891-5. PubMed ID: 19342479
[TBL] [Abstract][Full Text] [Related]
15. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
[TBL] [Abstract][Full Text] [Related]
16. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN.
Takiuchi T; Nakagawa T; Tamiya H; Fujita H; Sasaki Y; Saeki Y; Takeda H; Sawasaki T; Buchberger A; Kimura T; Iwai K
Genes Cells; 2014 Mar; 19(3):254-72. PubMed ID: 24461064
[TBL] [Abstract][Full Text] [Related]
17. PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes.
Thuille N; Wachowicz K; Hermann-Kleiter N; Kaminski S; Fresser F; Lutz-Nicoladoni C; Leitges M; Thome M; Massoumi R; Baier G
PLoS One; 2013; 8(1):e53709. PubMed ID: 23335970
[TBL] [Abstract][Full Text] [Related]
18. Nuclear export of the NF-κB inhibitor IκBα is required for proper B cell and secondary lymphoid tissue formation.
Wuerzberger-Davis SM; Chen Y; Yang DT; Kearns JD; Bates PW; Lynch C; Ladell NC; Yu M; Podd A; Zeng H; Huang TT; Wen R; Hoffmann A; Wang D; Miyamoto S
Immunity; 2011 Feb; 34(2):188-200. PubMed ID: 21333553
[TBL] [Abstract][Full Text] [Related]
19. The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor β (TGF-β) signaling and the development of regulatory T cells.
Zhao Y; Thornton AM; Kinney MC; Ma CA; Spinner JJ; Fuss IJ; Shevach EM; Jain A
J Biol Chem; 2011 Nov; 286(47):40520-30. PubMed ID: 21931165
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.
Jono H; Lim JH; Chen LF; Xu H; Trompouki E; Pan ZK; Mosialos G; Li JD
J Biol Chem; 2004 Aug; 279(35):36171-4. PubMed ID: 15226292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
